Drug Delivery Strategies and Novel Approaches for Cancer Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 28 February 2026 | Viewed by 83
Special Issue Editors
Interests: in vitro oncolopharmacology; novel anticancer approaches; drug repurposing; reversal of drug resistance; pharmacodynamics
Interests: nose-to-brain delivery; nanomedicine; albumin nanoparticles; polymeric micelles; freeze-drying
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite manuscripts to the Special Issue titled “Drug Delivery Strategies and Novel Approaches for Cancer Treatment”. The major goal of this Special Issue is to highlight advances in cancer therapy through the development of novel drug delivery systems and innovative approaches in the targeted therapy of malignancies.
Nanotechnology has revolutionized the way we treat solid tumors and hematologic malignancies through targeted delivery of cytotoxic or specific antitumor agents by enhanced bioavailability and reduced systemic toxicity. Simultaneously, drug repositioning—using registered drugs for new therapeutic indications—has emerged as a cost-effective and time-efficient strategy in oncology.
The Special Issue welcomes original research articles, reviews, and short communications focusing on, but not limited to, the following:
- Design and development of nanocarriers for chemotherapeutic agents and repurposed drugs;
- Mechanistic studies and biological interactions of nanocarrier-based formulations;
- Preclinical and clinical evaluation of repurposed anticancer agents;
- Targeted delivery and controlled release systems.
As Guest Editors, we encourage multidisciplinary contributions from researchers in pharmaceutics, oncology, nanomedicine, and related fields.
Dr. Zsuzsanna Schelz
Dr. Katona Gábor
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- drug delivery
- cancer therapy
- targeted delivery
- drug repurposing
- controlled release
- nanotechnology
- anticancer agents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
